Volera-Rosa Proba

The Volera-Rose test is a method for determining whether a patient has antibodies to the hepatitis B virus. This test is used to diagnose hepatitis B and its treatment.

The Volera-Rosa test was first described in 1961 by the Danish immunologist E. Vaaler and the American bacteriologist N. M. Rosa. The name comes from the names of the scientists who contributed to the development of this method.

The Volera-Rosa test is based on the reaction between the hepatitis B virus antigen and antibodies in the patient’s blood. The antigen is injected into the patient's body, and then a few days later blood is drawn for analysis. If the patient has antibodies to the virus, they will interact with the antigen, and this will lead to the appearance of specific staining on the test strip.

This method is very accurate and sensitive, and allows you to diagnose hepatitis B even in the early stages of the disease. The results of the Volera-Rosa test can be used to assess the effectiveness of hepatitis B treatment, as well as to monitor the spread of the virus in the population.

However, like any other diagnostic method, the Volera-Rosa test has its limitations. For example, it cannot be used to diagnose acute hepatitis B, since in this case there are no antibodies to the virus in the blood. Also, this method may be ineffective if the concentration of antibodies in the blood is low.

In general, the Volera-Rosa test is an important tool for diagnosing and monitoring hepatitis B. It allows you to quickly and accurately determine the presence of antibodies to the virus and evaluate the effectiveness of treatment.